Hard to Treat Diseases (HTDS)

[vis 2016]

Of course it is (or was):
You can see the product Cerebroprotein Hydrolysate on their website

SHENZHEN, CHINA--(Marketwire - Nov. 26, 2010) - Hard to Treat Diseases, Inc. (PINK SHEETS:HTDS) (www.htdsmedical.com) subsidiary Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announces that, after four years of continuous effort, the registration of Cerebroprotein Hydrolysate for Injection (Cognistar) has been approved by India's drug regulator, Drugs Controller General of India (DCGI).
As soon as the approval is finalized, Mellow Hope (www.mellowhope.com/en/main.asp) will launch this product in the local market